HYFT - NASDAQ

MindWalk Holdings Corp.

HYFT·NASDAQ

$1.82

+6.1%

HealthcareBiotechnology

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$84.87M

EPS-0.9100

P/E Ratio-2.00

Earnings Date03/26/2026

hyft

Other Current Liabilities

Last Annual Value

-1.03M

3-Year CAGR

-24%

5-Year CAGR

-5%

10-Year CAGR

Adjust for Inflation

MindWalk Holdings Corp. Competitors Analysis of Other Current Liabilities

HYFT · NASDAQ

Company	Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
MindWalk Holdings Corp. NASDAQ:HYFT	-1.03M	N/A	N/A	N/A
Quince Therapeutics, Inc. NASDAQ:QNCX	308.00K	-60.9%	11.3%	N/A
Unicycive Therapeutics, Inc. NASDAQ:UNCY	18.44M	12.0%	N/A	N/A
ALX Oncology Holdings Inc. NASDAQ:ALXO	14.42M	29.1%	32.5%	N/A
Fractyl Health, Inc. Common Stock NASDAQ:GUTS	6.00M	10.8%	3.2%	N/A
aTyr Pharma, Inc. NASDAQ:ATYR	9.79M	N/A	N/A	10.5%
Clene Inc. NASDAQ:CLNN	5.00M	33.1%	57.3%	N/A
CervoMed Inc. NASDAQ:CRVO	919.08K	-6.2%	69.4%	6.8%
Lite Strategy, Inc. NASDAQ:LITS	305.00K	-65.1%	-42.6%	N/A
XBiotech Inc. NASDAQ:XBIT	6.32M	124.0%	47.5%	28.3%
ImageneBio Inc NASDAQ:IMA	7.53M	30.4%	21.6%	N/A

MindWalk Holdings Corp. Fair Value Envelope

HYFT · NASDAQ

Our analysis suggests that HYFT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.82, this represents a potential HIDDEN relative to our calculated worth for MindWalk Holdings Corp..

HIDDEN

Intrinsic Value

Current Price: $1.82

Related Guides

Blog Categories

Continue your HYFT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.